RxDoctor Payments Data

John de Witt, MD

Gastroenterology · Indianapolis, INNPI 1346204401

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Olympus Medical Systems Corporation at 33.6% of the total. Reporting peaked in 2024 at $2,141 and has fallen 56.0% since, to $942 in 2025.

$4,581in general payments, 2019–2025

Across 30 payments — averaging $152.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Medical Systems Corporation$2K
  • Boston Scientific$1K
  • Wilson Cook Medical Incorporated$898
  • Intuitive Surgical$350
  • Steris Corporation$248
  • Cook Medical LLC$93
  • plus $102 from 3 others
$21,019in research payments, 2019–2025

Across 7 payments — averaging $3002.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vyaire Medical, Inc.$21K

What the payments were for

  • Consulting fees$2,39152%
  • Speaking & faculty fees$3508%
  • Travel & lodging$3658%
  • Food & beverage$1,47532%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,581 in reported general payments places this provider in the 65th percentile of 323 gastroenterology providers in Indiana.

See all gastroenterology providers in Indiana

Medicare billing

Part B allowed, 2024
$85,373
Medicare patients
310
Services billed
638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase13$65,628
Omeprazole81$1,397
Pantoprazole Sodium58$1,097
Esomeprazole Magnesium25$605
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl23$343
Fluconazole11$85
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$65
Ciprofloxacin Hcl12$60

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →